Log in to save to my catalogue

Targeting Tie2 for Treatment of Diabetic Retinopathy and Diabetic Macular Edema

Targeting Tie2 for Treatment of Diabetic Retinopathy and Diabetic Macular Edema

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1835634356

Targeting Tie2 for Treatment of Diabetic Retinopathy and Diabetic Macular Edema

About this item

Full title

Targeting Tie2 for Treatment of Diabetic Retinopathy and Diabetic Macular Edema

Publisher

New York: Springer US

Journal title

Current diabetes reports, 2016-12, Vol.16 (12), p.126-126, Article 126

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Tie2 is a tyrosine kinase receptor located predominantly on vascular endothelial cells that plays a central role in vascular stability. Angiopoietin-1 (Angpt1), produced by perivascular cells, binds, clusters, and activates Tie2, leading to Tie2 autophosphorylation and downstream signaling. Activated Tie2 increases endothelial cell survival, adhesi...

Alternative Titles

Full title

Targeting Tie2 for Treatment of Diabetic Retinopathy and Diabetic Macular Edema

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1835634356

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1835634356

Other Identifiers

ISSN

1534-4827

E-ISSN

1539-0829

DOI

10.1007/s11892-016-0816-5

How to access this item